Caliper Life Sciences Financial Market Data
| Last Close 04-Sep-2008 |
$2.94 |
Price/ Sales Ratio |
1.04 |
| 52-Week High |
$6.24 |
Price/ Book Ratio |
1.14 |
| 52-Week Low |
$2.15 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
1.1 |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$141.8 |
Return on Assets |
(12.2%) |
| Shares Outstanding (mil.) |
48.2 |
Return on Equity |
(18.1%) |
| Dividend Rate |
-- |
Current Ratio |
1.10 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
70 |
% Owned by Institutions |
64.0% |
| Latest Short Interest Ratio |
5.04 |
Latest Net Insider Transactions |
(993.00) |
| Revenue Growth |
12.3% |
69.0% |
508.8% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
